Form 4: BioCorRx Inc. Director Lourdes Felix Reports Acquisition of Shares as Compensation

Lourdes Felix, a Director and CEO/CFO of BioCorRx Inc., acquired 5,566 shares of common stock as compensation for her services, according to a recent SEC Form 4 filing.

Summary

• Lourdes Felix, Director and CEO/CFO of BioCorRx Inc. [BICX], reported a transaction on March 28, 2024.
• Ms. Felix acquired 5,566 shares of BioCorRx Inc. common stock.
• The shares were issued as compensation for her services as a director, pursuant to a Director Agreement dated March 1, 2019.
• The compensation is equivalent to $5,000 per quarter, based on the average closing price of the company's common stock on the three trading days immediately preceding the last day of the quarter.
• The average closing price used for this transaction was $0.90 per share.
• Following the transaction, Ms. Felix beneficially owns 80,395 shares of BioCorRx Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, indicating alignment with the company's interests. The compensation structure is also a positive aspect.

Positives

• The acquisition of shares by a director demonstrates alignment with the company's interests.
• The compensation structure provides ongoing incentives for Ms. Felix's continued service as a director.

Industry Context

This type of equity compensation is common for directors, aligning their interests with shareholders. It's a standard practice to incentivize board members.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The specific amount and vesting schedule vary widely based on company size, industry, and individual contributions.
• Comparing BioCorRx's director compensation to similar small-cap companies in the biotech or pharmaceutical sectors would provide a more detailed benchmark.

Related Party Transactions

• The issuance of shares to Lourdes Felix as compensation under the Director Agreement constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the director's stock ownership positively, as it aligns her interests with theirs.
• The consistent equity compensation may impact the company's cash flow and share dilution over time.

Key Dates

Keywords

BioCorRx Inc., BICX, Lourdes Felix, Director, CEO, CFO, Stock Acquisition, Compensation, SEC Form 4, Beneficial Ownership